06185.HK
CanSino Biologics, Inc.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 25.78
−0.46%Forward multiples
Based on analyst estimates
- P/E forward
- 75.54x
- P/E 2026E
- 66.07x
- P/E 2027E
- 23.61x
- P/E 2028E
- 11.76x
- P/S forward
- 11.04x
Trailing multiples
Trailing twelve months
- P/E TTM
- 183.31x
- PEG TTM
- 1.29x
- Price / book
- 1.08x
- Price / sales
- 4.34x
- Price / cash flow
- 56.45x
Enterprise value
- Enterprise value
- HKD 5.4B
- EV / sales
- 3.66x
- EV / EBITDA
- 105.42x
- EV / EBIT
- -88.70x
- Market cap
- HKD 6.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026